Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,776 products)
- Apoptosis(6,256 products)
- Cell Cycle/Checkpoint(4,788 products)
- Chromatin/Epigenetics(2,435 products)
- Cytoskeletal Signaling(1,522 products)
- DNA Damage/DNA Repair(2,964 products)
- Endocrinology/Hormones(3,706 products)
- Enzyme(3,668 products)
- GPCR/G-Protein(8,997 products)
- Immunology and Inflammation(3,862 products)
- Influenza Virus(301 products)
- JAK/STAT signaling(414 products)
- MAPK Signaling(1,249 products)
- Membrane Transporter/Ion Channel(3,027 products)
- Metabolism(10,206 products)
- Microbiology/Virology(7,577 products)
- Neuroscience(10,378 products)
- Other Inhibitors(36,080 products)
- Oxidation-Reduction(43 products)
- PI3K/Akt/mTOR Signaling(1,446 products)
- Proteases/Proteasome(1,726 products)
- Stem Cell and Derivatives(825 products)
- Tyrosine Kinase/Adaptors(2,039 products)
- Ubiquitination(1,714 products)
Show 16 more subcategories
Found 66691 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Human carbonic anhydrase II-IN-2
Compound R-13, a potent inhibitor of hCA I/II/IV/IX with K i s of 60.7, 320.7, 2298, and 35.2 nM.Formula:C20H25N3O4SColor and Shape:SolidMolecular weight:403.5HDAC6-IN-12
HDAC6-IN-12 is a potent inhibitor of HDAC6 that binds in the DNA chain, causing DNA damage and exhibiting anticancer effects that can be used in cancer researchFormula:C24H39F2N3O5Color and Shape:SolidMolecular weight:487.58Leukotriene B4 dimethyl amide
CAS:LTB4 dimethyl amide: inhibits human neutrophil degranulation and rat lysozyme release; antagonizes LTB4 receptor on guinea pig lung membranes (Ki = 130 nM).Formula:C22H37NO3Color and Shape:SolidMolecular weight:363.53NLRP3-IN-8
CAS:NLRP3-IN-8, orally active inflammasome blocker, IC50 of 1.23μM, stable (t1/2 = 138.63min), non-toxic (IC50 >100μM).Formula:C23H20N2O6Color and Shape:SolidMolecular weight:420.41YM-355179
CAS:YM-355179 is a novel, selective antagonist of CC chemokine receptor 3 with oral activity.Formula:C33H34FN4O7Purity:98%Color and Shape:SolidMolecular weight:617.64(RS)-AMPA monohydrate
CAS:(RS)-AMPA monohydrate, potent glutamate analogue, selectively activates L-glutamic acid without affecting kainic acid or NMDA receptors.Formula:C7H12N2O5Color and Shape:SolidMolecular weight:204.182OICR-9429-N-C2-NH2
CAS:OICR-9429-N-C2-NH2, a ligand for WDR5, intermediate 2, serves as a crucial compound in the synthesis of PROTACs.Formula:C31H38F3N7O2Color and Shape:SolidMolecular weight:597.687EFdA-TP tetrasodium
CAS:EFdA-TP tetrasodium is a potent HIV-1 inhibitor that blocks DNA synthesis as an ICT or DCT.Formula:C12H11FN5Na4O12P3Purity:98%Color and Shape:SolidMolecular weight:621.12PCSK9-IN-16
CAS:PCSK9-IN-16, holds potential for research into hypercholesterolemia and other cardiovascular diseases [1].Formula:C16H20N6O2S3Color and Shape:SolidMolecular weight:424.56AHR antagonist 5 hemimaleate
Potent oral AHR antagonist with IC50 < 0.5 μM, hinders tumor growth with anti-PD-1.Formula:C29H28FN7O4Color and Shape:SolidMolecular weight:499.55Antioxidant agent-8
Antioxidant agent-8, an oral Aβ 1-42 inhibitor, reduces fibril aggregation & promotes disaggregation; it's neuroprotective & BBB permeable.Formula:C13H12O5Color and Shape:SolidMolecular weight:248.23SB-612111
CAS:SB-612111: potent ORL-1 antagonist, Ki=0.33 nM; μ-, κ-, δ-receptor Ki=57.6, 160.5, 2109 nM; blocks nociceptin's pain effect.Formula:C24H29Cl2NOColor and Shape:SolidMolecular weight:418.40MRTX849 ethoxypropanoic acid
CAS:MRTX849 is a KRAS G12C ligand and PROTAC linker for creating potent LC-2, degrading KRAS G12C with DC50 of 0.25-0.76 μM.Formula:C37H43ClFN7O5Color and Shape:SolidMolecular weight:720.24TrxR-IN-2
TrxR-IN-2 is a potential thioredoxin reductase (TrxR) inhibitor. TrxR-IN-2 has research value in the chemotherapy of drug-resistant hepatocellular carcinoma.Formula:C22H22N4O4Color and Shape:SolidMolecular weight:406.43Zetomipzomib
CAS:KZR-616: Immunoproteasome inhibitor targeting LMP7 (IC50: 39/57 nM) & LMP2 (IC50: 131/179 nM), potential in autoimmune disease research.Formula:C30H42N4O8Color and Shape:SolidMolecular weight:586.68ErSO-DFP
ErSO-DFP activates a-UPR, targets ERα+ cancer cells with high selectivity, and effectively reduces MCF-7 tumours.Formula:C20H17F5N2O2Color and Shape:SolidMolecular weight:412.35SPR-00305
CAS:SPR-00305 is a novel potent inhibitor of the mvfr pathwayFormula:C24H19ClN2O3Color and Shape:SolidMolecular weight:418.87TDI-11861
CAS:TDI-11861 is a second-gen sAC (ADCY10) inhibitor with an IC50 of 5.5 nM and slow dissociation.Formula:C22H25ClF2N6O3Color and Shape:SolidMolecular weight:494.92S1P1 agonist 5
Selective oral S1P1 agonist 5 inhibits lymphocyte drainage, potential for MS research.Formula:C23H24ClN2NaO4Color and Shape:SolidMolecular weight:450.89
